COLY-MYCIN S Drug Patent Profile
✉ Email this page to a colleague
When do Coly-mycin S patents expire, and when can generic versions of Coly-mycin S launch?
Coly-mycin S is a drug marketed by Endo Operations and Parke Davis and is included in two NDAs.
The generic ingredient in COLY-MYCIN S is colistin sulfate. There are four drug master file entries for this compound. Additional details are available on the colistin sulfate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for COLY-MYCIN S?
- What are the global sales for COLY-MYCIN S?
- What is Average Wholesale Price for COLY-MYCIN S?
Summary for COLY-MYCIN S
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 2 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 12 |
| DailyMed Link: | COLY-MYCIN S at DailyMed |
Pharmacology for COLY-MYCIN S
| Drug Class | Aminoglycoside Antibacterial Corticosteroid |
| Mechanism of Action | Corticosteroid Hormone Receptor Agonists |
US Patents and Regulatory Information for COLY-MYCIN S
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Endo Operations | COLY-MYCIN S | colistin sulfate; hydrocortisone acetate; neomycin sulfate; thonzonium bromide | SUSPENSION/DROPS;OTIC | 050356-001 | Approved Prior to Jan 1, 1982 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Parke Davis | COLY-MYCIN S | colistin sulfate | SUSPENSION;ORAL | 050355-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
